首页> 外国专利> (6S, 9AS) -N-BENZYL-6 - (4-HYDROXYPHENYL) METHYL -4,7-DIOXO-8 - ({6- 3- (PIPERAZIN-1-IL) AZETIDIN-1-IL PYRIDINE -2-IL} METHYL) -2- (PROP-2-EN-1-IL) -OKTAHYDRO-1H-PYRAZINO 2,1-C 1,2,4 TRIAZIN-1-CARBOXAMIDE COMPOUND

(6S, 9AS) -N-BENZYL-6 - (4-HYDROXYPHENYL) METHYL -4,7-DIOXO-8 - ({6- 3- (PIPERAZIN-1-IL) AZETIDIN-1-IL PYRIDINE -2-IL} METHYL) -2- (PROP-2-EN-1-IL) -OKTAHYDRO-1H-PYRAZINO 2,1-C 1,2,4 TRIAZIN-1-CARBOXAMIDE COMPOUND

机译:(6S,9AS)-N-苄基-6-[(4-羟基苯甲基)] -4,7-二氧-8-({6- [3-(哌嗪-1-IL)ZE丁啶-1-IL]吡啶-2-IL}甲基)-2-(PROP-2-EN-1-IL)-OKTAHYDRO-1H-PYRAZINO [2,1-C] [1,2,4]三嗪-1-甲酰胺化合物

摘要

A compound represented by formula (1) or pharmaceutically acceptable salt thereof: wherein R 1 is a C 1-6 alkyl group; R 2 and R 3 are the same or different from each other and each is a hydrogen atom or a C 1-6 alkyl group; X 2 , X 3 and X 4 are the same or different from each other and each is a hydrogen atom or a halogen atom; and X 5 is a hydrogen atom or - P(=O)(OH) 2 has a Wnt Pathway modulating activity.
机译:式(1)表示的化合物或其药学上可接受的盐:其中R 1为C 1-6烷基; R 2和R 3相同或不同,分别为氢原子或碳数1〜6的烷基。 X 2,X 3和X 4相同或不同,分别为氢原子或卤素原子。 X 5为氢原子或-P(= O)(OH)2具有Wnt途径调节活性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号